Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prospective Observational Study on ES-SCLC
A prospective observational study on extensive-stage and small cell lung cancer conducted by Peking Union Medical College Hospital is not ye…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Real-world study evaluating adebrelimab-based combination regimens for advanced solid tumors. The conditions include non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating pharmacogenomics and SNP guidance for topotecan in small cell lung cancer. The study is currentl…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer [Phase 1]
This document notes an ongoing Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of BMS-986489 i…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer [NA]
An ongoing clinical trial is evaluating radiotherapy strategies as part of combined treatment for small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing [Phase 1, Phase 2]
This clinical trial update describes an umbrella study for recurrent, extensive-stage small cell lung cancer guided by molecular typing, spa…
-
FDA approval · 2025-08-25FDA Approved: COSELA — Supplemental Application (G1 Therapeutics, Inc.)
FDA approved a supplemental application for COSELA (trilaciclib) from G1 Therapeutics.
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update reports results from evaluating the combination of sirolimus and auranofin in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors [Phase 1]
This Phase 1 trial assesses safety, tolerability, and preliminary efficacy of lomvastomig, a PD-1/TIM-3 bispecific antibody, in adults with …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC [NA]
An ongoing study sponsored by Fudan University is evaluating a combination of liposomal irinotecan and anlotinib as a second-line treatment …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Perioperative Immunotherapy for Resectable Limited-Stage SCLC [Phase 2]
A Phase 2 trial is evaluating perioperative immunotherapy for resectable limited-stage small cell lung cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer [Phase 1]
A Phase 1 clinical trial update for BT02 in advanced lung cancer, including Non-Small Cell Lung Cancer and Small Cell Lung Cancer, with stat…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer [Phase 2, Phase 3]
A phase 2/3 clinical trial update comparing organoid-guided therapy to Topotecan for relapsed extensive-stage small cell lung cancer, with t…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer [Phase 1]
A Phase 1 dose-escalation trial of the investigational drug ZG006 in patients with small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating concurrent chemoradiotherapy with dual immune checkpoint blockade for limited-stage small cell lung c…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy [Phase 3]
Phase 3 study evaluating durvalumab with tremelimumab versus durvalumab alone and placebo in limited-stage small cell lung cancer patients w…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
The document reports a clinical trial on small-cell lung cancer that is currently recruiting. The study emphasizes community engagement to e…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033 [Phase 2]
This is a Phase 2 randomized study protocol evaluating toripalimab plus chemotherapy as adjuvant therapy after radical resection for postope…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
This clinical trial will evaluate the incidence of clinically suspicious Lambert-Eaton myasthenic syndrome in subjects diagnosed with small …
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET [Phase 2]
A Phase 2 trial of iadademstat in combination with paclitaxel for relapsed/refractory small-cell lung cancer and extrapulmonary high-grade n…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer. [Phase 2]
A Phase II clinical trial studying QL1706 combined with anti-angiogenesis therapy and chemotherapy in extensive-stage small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms [Phase 2, Phase 3]
Clinical trial update for a pharmacogenomics study of etoposide in small cell lung cancer, spanning Phase 2 and Phase 3, with status active …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) [Phase 2]
Phase 2 results evaluate pembrolizumab in combination with chemotherapy and investigational agents as first-line therapy for extensive-stage…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer [NA]
This clinical trial update reports on a study evaluating Zusanli (ST36) electroacupuncture in conjunction with neoadjuvant immunotherapy for…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy [Phase 2]
A Phase 2 clinical trial protocol evaluating prophylactic proton pump inhibition to protect the esophagus during lung radiation therapy, cur…